Skip to content

Safety and Efficacy of Fetoscopes Used in Fetoscopic Selective Laser Photocoagulation

Safety and Efficacy of Fetoscopes Used in Fetoscopic Selective Laser Photocoagulation for Complicated Monochorionic-Diamniotic Pregnancies

Status
Withdrawn
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06022510
Enrollment
0
Registered
2023-09-05
Start date
2025-04-01
Completion date
2025-04-01
Last updated
2026-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Twin Monochorionic Diamniotic Placenta

Keywords

twin-twin transfusion syndrome, TTTS, twin anemia polycythemia sequence, TAPS, selective intrauterine growth restriction, sIUGR

Brief summary

The purpose of this study is to evaluate the safety and efficacy of the investigational fetoscopes used in patients undergoing fetoscopic selective laser photocoagulation for complicated monochorionic-diamniotic pregnancies.

Detailed description

All patients who choose to undergo fetoscopic selective laser photocoagulation (S-PLC) at Texas Children's Fetal Center will be offered participation in this research study by study investigators. Description of study rationale and design and a focused interview by the study coordinator to afford potential participants a formal opportunity to examine what they have learned about the research study in the course of their evaluation and discuss how they feel about enrolling in the research study. Once the patient is deemed eligible the informed consent process will be reviewed. If patients elect to participate in the study, informed consent will be obtained, and patients provided a copy of the signed consent. Fetoscopic Procedure: Selective laser photocoagulation (S-PLC) is standard of care for the treatment of complicated monochorionic twin pregnancies and will be performed with the same technique in this study as it is with the use of the currently approved fetoscopes. In the majority of cases, in utero access has been achieved using a small percutaneous incision under ultrasound guidance with the instruments inserted through the maternal abdomen, uterine wall and into the recipient fetus' gestational sac. The fetoscope is then used to "map" the placental vascular pattern. Communicating vessels between the fetuses are ablated using laser energy via a 400-600 micron laser fiber that has been introduced through the instrument channel of the operating sheath. Intravenous sedation with local anesthesia at the site of insertion has been found to provide sufficient maternal anesthesia for the procedure. At the completion of the S-PLC, the excess amniotic fluid in the recipient twin's sac is removed to achieve a normal volume. Follow-Up: The investigators will follow patients for the immediate post-procedure period (until they leave the OR).

Interventions

DEVICEFetoscopy Sets for Anterior and Posterior Placentas

Patients who choose to undergo fetoscopic surgery for a complicated monochorionic-diamniotic pregnancy will be offered participation in this study. All patients will undergo selective laser photocoagulation with the use of the fetoscopes in this study.

Sponsors

Michael A Belfort
Lead SponsorOTHER
Baylor College of Medicine
CollaboratorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients who are eligible and elect to undergo fetoscopic selective laser photocoagulation for the treatment of complicated monochorionic-diamniotic pregnancies.

Exclusion criteria

* Patients who do not elect to undergo fetoscopic laser photocoagulation for treatment of complicated monochorionic-diamniotic pregnancies.

Design outcomes

Primary

MeasureTime frameDescription
Number of adverse eventsImmediate Post-Procedure Period (from surgery start until surgery finish)Number of adverse events associated with the investigational device.
Number of device defects, malfunctions, or failuresImmediate Post-Procedure Period (from surgery start until surgery finish)Number of device defects, malfunctions, or failures and whether the device performed as intended.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORMichael A Belfort, MD

Baylor College of Medicine

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 30, 2026